patients referred for investigation is rising rapidly. New referrals to the Edinburgh sleep clinic Background -A study was undertaken to test the hypothesis that unsupervised dom-increased 10-fold between 1990 and 1996.
of cataplexy or periodic leg movement disorder. electrocardiogram, chest wall movement by electrical impedance, and finger pulse oximetry. Control patients were new patients living >30 miles from the laboratory who attended the Studies were transferred to paper and scored manually. Apnoea was defined as a cessation same initial referral clinics as the subjects for the prospective trial (one control selected for of airflow for >10 seconds and hypopnoea was defined as a reduction of >50% in chest wall every two trial patients at a clinic) and who followed our normal investigation protocol of movement for >10 seconds. Frequencies of events were calculated per hour of recording. laboratory polysomnography booked at the time of the clinic. Data from control patients Studies without four hours of interpretable recording were regarded as technically unwere used for comparison of costs, duration of investigation, and outcome.
satisfactory.
 
Subjects underwent inpatient polysomnography on night 1. The next morning a trained  All subjects or controls who later attended sleep technician educated them in the use of the portable sleep study system which they took for laboratory titration for nasal continuous positive airway pressure therapy (CPAP) were home to record themselves unsupervised on night 2 and then returned the next day for classified as having been offered CPAP therapy.
Those still in possession of a CPAP system in analysis.
November 1996 (4-20 months after diagnosis) were classified as continuing CPAP. Objective CPAP usage was calculated from the number   The diagnostic criteria used in this protocol of hours running time registered on the CPAP unit's in-built time clock documented at the were based on the results of the validation trial (see results below). Subjects underwent a home most recent clinic attendance, averaged over the number of days since the previous recording study as an initial investigation after education in the use of the equipment. Home studies (median 94 days, range 10-372).
The cost of inpatient polysomnographic showing >30 apnoeas+hypopnoeas (A+H) per hour of recording were regarded as diag-studies and home studies included capital depreciation of equipment, disposable equipnostic of SAHS and these subjects proceeded to treatment without further investigation. Sub-ment, medical, technician and nursing time.
The cost of overnight hospital stay was included jects whose home studies showed <30 A+H per hour and who denied daytime sleepiness in the cost of the laboratory studies. For the portable system we assumed 1000 nights' use were not investigated further but were given appropriate advice. The remaining subjects, before replacement and allowed travel expenses for the patient's additional journey to return including those in whom the home study was unsuccessful, were further investigated with the equipment.
Time to diagnosis was the number of days overnight polysomnography in the laboratory and managed thereafter according to our usual between the clinic attendance when the decision was taken to investigate with a sleep practice. Bookings for polysomnography were given the same priority as those for control and study, and the date of the study which provided a diagnosis on which management could be non-trial patients.
based. Costs and times for subjects in the prospective protocol who underwent two sleep studies allow for both studies.  Overnight laboratory polysomnography recorded an electroencephalogram (two channels), electro-oculogram (four channels), submental electromyogram, bilateral anterior tibial electromyogram, electrocardiogram,  
The two forms of sleep study were compared summed oronasal airflow by thermocouple, thoracic and abdominal movement by in-in the validation trial by the method of Bland and Altman for the assessment of agreement ductive plethysmography, and ear pulse oximetry. Data were collected on a computerised between methods of clinical measurement.
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Normally distributed values are quoted as recording system (Compumedics, Melbourne, Australia) but all interpretation and scoring means with standard deviation, and the significance of differences was assessed by the was performed manually by experienced technicians. Sleep was scored on screen by con-two-tailed Student's t test. Other values are quoted as medians with range and compared ventional criteria. 20 Apnoea was defined as the cessation of airflow for >10 seconds, and hypo-with the two-tailed Mann-Whitney U test.
Where more than one set of variables was pnoea as a reduction of >50% in thoracoabdominal movement for >10 seconds. The 20 home studies showed a median of 25 A+H/hour of recording (range 6-45). Polyage 50 (9) years and mean (SD) body mass index (BMI) 30 (4) kg/m 2 completed the pro-somnography showed a median of 27 A+H/ hour of sleep (range 2-67) ( fig 1A) . The mean tocol. Twenty of the 23 home studies produced (SD) difference between these scores (polysomnographic minus home study) was +8 (12). A Bland-Altman plot 22 comparing the difference between each pair of results with the mean value of each pair ( fig 1B) showed a bias to lower scores on home studies at higher A+H values. The home study A+H/hour recording did, however, correlate significantly with the polysomnography A+H/hour asleep (r=0.8, p<0.001, fig 1A) .
When the home study scores were compared with the polysomnographic frequency of A+H/ hour in bed (median 20 A+H/hour, range 2-50) rather than A+H/hour asleep, the Bland-Altman plot showed no bias ( fig 1C) . The mean (SD) difference was −1 (11) giving limits of agreement 22 (mean difference± 1.96SD between which 95% of differences should lie) of −22 to +21.
To obtain a criterion for diagnosis of SAHS from a home sleep study for use in the prospective trial we examined the paired results from the validation trial ( fig 1A) . A frequency of >15 A+H/hour asleep on polysomnography defines a group of patients who are known to benefit from CPAP therapy 23 and is used in our laboratory as the criterion for a diagnosis of SAHS. All subjects who had a home study score of >20 A+H/hour recording showed >15 A+H/hour asleep on polysomnography. However, the scatter of the paired results suggested that a home study diagnostic cut off of >20 A+H/hour might result in false positive diagnoses when larger numbers were studied so a more conservative criterion for diagnosis of SAHS from a home study of >30 A+H/hour recording was adopted for use in the prospective trial.
 
Of an initial 150 subjects (table 1) pleted the protocol. One subject defaulted after an unsuccessful home study. in terms of age, BMI, or subjective daytime sleepiness (Epworth Sleepiness Scale (ESS) 24 at time of initial clinic attendance) from those 33 (10) 31 (5) 32 (7) showed >30 A+H/hour recording confirming (p=0.1) (p>0.5) a diagnosis of SAHS. Of these, 40 subjects
Significances refer to differences from control group.
commenced CPAP therapy (characteristics in <30 A+H/hour recording and four (3%) of these showed <15 A+H/hour recording (table  3) .
    
The cost of a home study was calculated as £46 and the cost of a laboratory study as £210. The mean cost and median duration of investigation in the 150 prospective trial subjects, allowing for both studies in those who (table 4). The reduction in duration of investigation was due to the avoidance of waiting times for laboratory investigation. home study scores of 20-30 A+H/hour recording would not have undergone polysomnography and would have proceeded directly to treatment. Three of these subjects table 1), two were referred for tonsillectomy, and one declined treatment.
in fact had polysomnography scores of <15 A+H/hour slept and have not been treated Eighty subjects had successful home studies (54%) showing <30 A+H/hour recording of with CPAP under our standard protocols, so the reduced inconvenience to 15 patients whom 18 (with studies showing a median of 8 A+H/hour, range 3-19) denied troublesome through avoiding inpatient studies must be set against the possibly inappropriate initiation of daytime sleepiness (median ESS 4.5, range 0-12) and four others declined further in-CPAP therapy in three patients. The relative inconvenience to patients cannot be quantified, vestigation. These subjects were not investigated further but were given advice but the financial effects can be calculated. The minimum initial cost for CPAP therapy for appropriate to their complaints. The remaining 58 subjects (median 16 A+H/hour, range 2-three patients is £2121 (£707 per patient for CPAP education, CPAP titration study, and 29) proceeded to overnight laboratory polysomnography. Including 26 whose home provision of CPAP system). The financial savings from avoiding 15 laboratory studies would studies were unsuccessful, a total of 84 subjects (56%) required polysomnography under this be £3150 (15×£210) giving a potential overall saving of £1029 or £6.86 per subject in the protocol.
Scores from polysomnography and home prospective trial. Similarly, a diagnostic threshold of 25 A+H/ studies can therefore be compared in 58 subjects who, by definition, had home studies hour on home studies could have reduced the number of subjects undergoing laboratory studshowing <30 A+H/hour but complained of group.bmj.com on April 19, 2017 -Published by http://thorax.bmj.com/ Downloaded from ies by nine, of whom two had <15 A+H/hour by this criterion will tend to reduce the practical benefits shown by the home studies protocol. on polysomnography and have not proceeded routinely to CPAP. The overall cost saving
The prospective trial confirms the practicality of an investigative protocol based on comes to £476 (£3.17 per subject), again without quantifying the inconvenience to the home studies for local patients, with an acceptably low rate of technically unsuccessful patients. studies once patients with obvious relevant disabilities are excluded. The results suggest, however, that home studies alone cannot exclude      a diagnosis of SAHS in patients with daytime  sleepiness. In the group most likely to present When the subjects who had followed the home diagnostic problems -that is, those with daystudy protocol were compared with the control time sleepiness but a low or normal home study patients there was no difference in the pro-score (<30 A+H/hour recording) -the limited portion offered CPAP, the proportion con-home studies failed to identify several subjects tinuing CPAP, or their nightly usage of CPAP. who had severe SAHS on polysomnography. CPAP usage was also identical in the subset The reason for the discrepancy is likely to be whose only investigation was a home study a combination of factors including the night- (table 4) .
to-night variation in respiratory abnormality seen in any sleep study 25 which is more marked in those with mild SAHS, 26 the tendency of the limited home study to underestimate the Discussion This study shows that an investigative protocol frequency of sleep-related abnormalities in subjects who spend a significant part of the night based on home sleep studies can be used to diagnose SAHS with similar treatment out-awake since actual sleep time is not recorded, and the different techniques for recording rescome compared with a protocol using laboratory polysomnography alone and with reduced piratory variables. This illustrates the potential for diagnostic error suggested by the validation costs. There is also a benefit in reduced investigation time that is dependent on the wait-study and suggests that sleep services or research trials depending solely on home limited ing time for laboratory investigation and will vary between different centres. In our centre sleep studies may underestimate the severity of SAHS or miss the diagnosis in an important use of this investigative protocol reduced the demand for laboratory polysomnography by group of patients.
Debate continues as to whether CPAP treat-44% and so cut the waiting time for all sleep laboratory investigations. The reduced contact ment should be guided by the frequency of respiratory irregularity alone. Pressure for criwith laboratory staff and loss of some opportunities for patient education did not affect terion based therapy from purchasers in the UK and evidence based approaches overseas 27 the final outcome in terms of the subjects' uptake or nightly usage of CPAP. We would, are demanding strict definitions as to which SAHS patients should receive CPAP. The however, emphasise the importance of expert technical support for explanation of the use of standard protocol in our laboratory is to offer CPAP to all those with a polysomnographic the portable equipment, CPAP education and mask fitting, and particularly for interpretation AHI of >15/hour who have troublesome sleepiness. To make a positive diagnosis of SAHS of the raw home study data which was all performed manually. from a home study we continue to use the conservative criterion of >30 A+H/hour reThe validation trial shows that, in our clinic population, the EdenTrace sleep study system cording which was derived from the validation trial. The prospective trial indicates that a lower used at home produces a score that correlates with the polysomnographic A+H averaged cut off would result in a small number of false positive diagnoses and give a small initial over sleep time (also known as the apnoea/ hypopnoea index, AHI) and is thus potentially benefit in financial terms through reducing the number of laboratory studies. Given the inusable as a diagnostic test for SAHS. However, in terms of actual agreement of recording convenience for patients of an inappropriate trial of CPAP therapy as well as the psychomethods rather than correlation, the variable measured during a home study (A+H averaged logical and legal consequences of a false diagnosis, we have concluded that in our future over recording time) is equivalent to the polysomnographic frequency of respiratory events practice the diagnostic criterion for home studies should not be changed. therefore not identical to the polysomnography AHI, and diagnostic criteria derived from polysomnography should be applied with caution. 
